305 related articles for article (PubMed ID: 11068652)
1. Nasal polyposis: from cytokines to growth.
Bachert C; Gevaert P; Holtappels G; Cuvelier C; van Cauwenberge P
Am J Rhinol; 2000; 14(5):279-90. PubMed ID: 11068652
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
Shin SH; Park JY; Jeon CH; Choi JK; Lee SH
Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
[TBL] [Abstract][Full Text] [Related]
3. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
[TBL] [Abstract][Full Text] [Related]
4. [Study on the role of interleukin-5 and eosinophil cationic protein and the correlation between them in nasal polyp].
Wang J; Ma R; Yang H; Zhou H; Liu Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):272-4. PubMed ID: 12916352
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1.
Lee YM; Kim SS; Kim HA; Suh YJ; Lee SK; Nahm DH; Park HS
J Korean Med Sci; 2003 Feb; 18(1):97-102. PubMed ID: 12589095
[TBL] [Abstract][Full Text] [Related]
6. [The role of chemokines in nasal polyps].
Caversaccio M; Hartnell A; Calnan D; Jose P; Mackay IS; Uguccioni M; Baggiolini M; Williams TJ; Conroy DM
Schweiz Med Wochenschr; 2000; Suppl 125():92S-95S. PubMed ID: 11141953
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilic inflammation in allergic rhinitis and nasal polyposis.
Perić A; Vojvodić D; Vukomanović-Đurđević B; Baletić N
Arh Hig Rada Toksikol; 2011 Dec; 62(4):341-8. PubMed ID: 22202468
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
9. Distribution of eosinophil granule proteins in nasal mucosa of atopic patients with nasal polyposis.
Min YG; Kim YJ; Yun YS
ORL J Otorhinolaryngol Relat Spec; 1996; 58(2):82-6. PubMed ID: 8736052
[TBL] [Abstract][Full Text] [Related]
10. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
[TBL] [Abstract][Full Text] [Related]
11. Chronic rhinosinusitis--need for further classification?
Rudack C; Sachse F; Alberty J
Inflamm Res; 2004 Mar; 53(3):111-7. PubMed ID: 15021966
[TBL] [Abstract][Full Text] [Related]
12. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.
Bachert C; Gevaert P; Holtappels G; Johansson SG; van Cauwenberge P
J Allergy Clin Immunol; 2001 Apr; 107(4):607-14. PubMed ID: 11295647
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of chronic sinus diseases by measurement of inflammatory mediators.
Van Zele T; Claeys S; Gevaert P; Van Maele G; Holtappels G; Van Cauwenberge P; Bachert C
Allergy; 2006 Nov; 61(11):1280-9. PubMed ID: 17002703
[TBL] [Abstract][Full Text] [Related]
14. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
Kramer MF; Ostertag P; Pfrogner E; Rasp G
Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil infiltration and activation in nasal polyposis.
Fan GK; Wang H; Takenaka H
Acta Otolaryngol; 2007 May; 127(5):521-6. PubMed ID: 17453479
[TBL] [Abstract][Full Text] [Related]
16. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
Yoshifuku K; Matsune S; Ohori J; Sagara Y; Fukuiwa T; Kurono Y
Rhinology; 2007 Sep; 45(3):235-41. PubMed ID: 17956026
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis.
Scavuzzo MC; Fattori B; Ruffoli R; Rocchi V; Carpi A; Berni R; Giambelluca MA; Giannessi F
Biomed Pharmacother; 2005 Jul; 59(6):323-9. PubMed ID: 15935609
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
[TBL] [Abstract][Full Text] [Related]
19. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
20. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.
Yamada T; Miyabe Y; Ueki S; Fujieda S; Tokunaga T; Sakashita M; Kato Y; Ninomiya T; Kawasaki Y; Suzuki S; Saito H
Front Immunol; 2019; 10():74. PubMed ID: 30778348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
